Status: current, Primitive. Date: 31-Jul 2014. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3009274019 | Aflibercept | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3009606010 | Aflibercept (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aflibercept | Has disposition | Vascular endothelial growth factor receptor antagonist | true | Inferred relationship | Some | ||
| Aflibercept | Is a | Vascular endothelial growth factor receptor antagonist | true | Inferred relationship | Some | ||
| Aflibercept | Is a | Fusion protein | true | Inferred relationship | Some | ||
| Aflibercept | Is a | Angiogenesis inhibitor | true | Inferred relationship | Some | ||
| Aflibercept | Has disposition | Angiogenesis inhibitor | true | Inferred relationship | Some | ||
| Aflibercept | Is a | Antineoplastic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aflibercept only product | Has active ingredient | True | Aflibercept | Inferred relationship | Some | 1 |
| Aflibercept only product in parenteral dose form | Has active ingredient | True | Aflibercept | Inferred relationship | Some | 1 |
| Aflibercept 40 mg/mL solution for injection | Has BoSS | True | Aflibercept | Inferred relationship | Some | 1 |
| Aflibercept 40 mg/mL solution for injection | Has precise active ingredient | True | Aflibercept | Inferred relationship | Some | 1 |
| Aflibercept-containing product | Has active ingredient | True | Aflibercept | Inferred relationship | Some | 1 |
| Aflibercept-containing product in parenteral dose form | Has active ingredient | True | Aflibercept | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR